Meteora Capital, LLC 13D and 13G filings for NKGen Biotech, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 10:34 am Purchase |
2024-12-31 | 13G | NKGen Biotech, Inc. Common Stock NKGN |
Meteora Capital, LLC | 2,772,145 7.840% |
2,772,145 (New Position) |
Filing |
| 2024-05-10 2:42 pm Sale |
2024-05-10 | 13G | NKGen Biotech, Inc. Common Stock NKGN |
Meteora Capital, LLC | 0 0.000% |
-1,596,817 (Position Closed) |
Filing |
| 2024-02-14 1:05 pm Purchase |
2023-12-31 | 13G | NKGen Biotech, Inc. Common Stock NKGN |
Meteora Capital, LLC | 1,596,817 7.300% |
1,596,817 (New Position) |
Filing |